Inventor · disambiguated record
Ehab M. Khalil
Also filed as: KHALIL EHAB · KHALIL EHAB M
22 granted patents·5 pending applications·295 citations·filing 1998–2022
96Inventor score
Files withCELGENE CORP13DIMENSIONAL PHARM INC3JANSSEN PHARMACEUTICA NV3SCOTT RICHARD W2UNIV ROCKEFELLER2
Top patents by PatentIndex Score
27 records- 0197US9499514B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2015·Granted Nov 22, 2016·28 cites·29 claims
- 0297US8518972B2Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the sameMAN HON-WAH·Filed 2011·Granted Aug 27, 2013·74 cites·7 claims
- 0395US9828361B2Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the sameCELGENE CORP·Filed 2016·Granted Nov 28, 2017·12 cites·10 claims
- 0494US9808451B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2016·Granted Nov 7, 2017·12 cites·19 claims
- 0593US9822094B2Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the sameCELGENE CORP·Filed 2016·Granted Nov 21, 2017·9 cites·12 claims
- 0692US9968596B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2017·Granted May 15, 2018·8 cites·26 claims
- 0792US8030305B2Triazolopyridazines as kinase modulatorsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Oct 4, 2011·24 cites·18 claims
- 0890US11241423B2Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2019·Granted Feb 8, 2022·2 cites·6 claims
- 0990US9309219B2Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the sameCELGENE CORP·Filed 2013·Granted Apr 12, 2016·8 cites·17 claims
- 1089US8173654B2Triazolopyridazine compoundsLU TIANBAO·Filed 2008·Granted May 8, 2012·21 cites·15 claims
- 1187US7138530B2Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditionsDIMENSIONAL PHARM INC·Filed 2003·Granted Nov 21, 2006·29 cites·48 claims
- 1284US10189814B2Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the sameCELGENE CORP·Filed 2017·Granted Jan 29, 2019·2 cites·23 claims
- 1384US8877780B25-substituted isoindoline compoundsMULLER GEORGE W·Filed 2008·Granted Nov 4, 2014·5 cites·5 claims
- 1484US8796275B2Anti-malarial compoundsSCOTT RICHARD W·Filed 2009·Granted Aug 5, 2014·6 cites·20 claims
- 1583US7109354B2Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditionsDIMENSIONAL PHARM INC·Filed 2003·Granted Sep 19, 2006·17 cites·16 claims
- 1682US2022411402A1Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the sameCELGENE CORP·Filed 2022·Application pending·0 cites
- 1779US2022387413A1Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2021·Application pending·0 cites
- 1878US7482376B2Conjugated complement cascade inhibitorsDIMENSIONAL PHARM INC·Filed 2004·Granted Jan 27, 2009·11 cites·11 claims
- 1974US11414399B2Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the sameCELGENE CORP·Filed 2020·Granted Aug 16, 2022·0 cites·9 claims
- 2072US10669257B2Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the sameCELGENE CORP·Filed 2018·Granted Jun 2, 2020·0 cites·6 claims
- 2164US2018221361A1Antiproliferative compounds and methods of use thereofCELGENE CORP·Filed 2018·Application pending·0 cites
- 2262US5990094AInhibitors of sorotonin N-acetyltransferaseUNIV ROCKEFELLER·Filed 1998·Granted Nov 23, 1999·14 cites·6 claims
- 2358US7868023B2Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditionsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Jan 11, 2011·0 cites·17 claims
- 2458US6369030B1Inhibitors of histone acetyltransferases (HATs) and uses thereofUNIV ROCKEFELLER·Filed 1999·Granted Apr 9, 2002·13 cites·2 claims
- 2557US2015072997A1Anti-malarial compoundsCELLCEUTIX CORP·Filed 2014·Application pending·0 cites
- 2652US7385066B2Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditionsJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Jun 10, 2008·0 cites·12 claims
- 2741US2012115877A1Facially Amphiphilic Compounds, Compositions, And Uses Thereof In Treating CancerSCOTT RICHARD W·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →